"Das DIABETES ZENTRUM WANDSBEK ist eine der ersten diabetologischen Schwerpunktpraxen in Hamburg. Wir haben es uns zur Aufgabe gemacht, Menschen mit Diabetes umfassend und spezialisiert im multiprofessionellen Team zu betreuen. Wir stehen für eine moderne und individuelle Diabetestherapie aller Diabetesformen, Folgeerkrankungen und kardiovaskulären Risikofaktoren. Wir sind ein durch die Deutsche Diabetes Gesellschaft (DDG) anerkanntes Behandlungszentrum für Menschen mit Diabetes sowie zertifizierte diabetologische Fußbehandlungseinrichtung und wurden mit der höchsten Qualitätsstufe "Diabetologikum DDG" ausgezeichnet. Wir haben ein Studienzentrum, in dem Studien aus dem Bereich der Diabetologie durchgeführt werden. Wir freuen uns auf Sie!"

During the past decade, Diabetes-Zentrum Wandsbek conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Diabetes-Zentrum Wandsbek" are "Chronic Kidney Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Diabetes-Zentrum Wandsbek" in a lesser frequency.

Most popular intervention types in "Diabetes-Zentrum Wandsbek" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Empagliflozin" (1 trials), "Finerenone (Kerendia, BAY94-8862 )" (1 trials), "Metformin" (1 trials) and "Sitagliptin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diabetes-Zentrum Wandsbek" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Diabetes-Zentrum Wandsbek". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Diabetes-Zentrum Wandsbek, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Diabetes-Zentrum Wandsbek, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".